Prednisolone

(redirected from Orapred)
Also found in: Dictionary, Thesaurus, Medical.

prednisolone

[pred′nis·ə‚lōn]
(biochemistry)
C21H28O5 A glucocorticoid that is a dehydrogenated analog of hydrocortisone.

Prednisolone

 

a synthetic medication; a hormonal preparation. It has an anti-inflammatory and antiallergic effect. It is used in the form of tablets, a solution for injection, and ointments for the treatment of rheumatism, arthritis, some kidney diseases, and bronchial asthma.

References in periodicals archive ?
BioMarin will also assume approximately $15 million dollars in liabilities of Medicis, which represents payments owed by Medicis to the original developers of Orapred.
CIMA could terminate Alliant's license in connection with Orapred on 30-days notice.
The value of these partnerships has been exemplified in the past year by Hi-Tech's ability to execute a license-and-supply agreement that delivered to the marketplace a generic equivalent to Orapred solution.
has launched a generic version of BioMarin's Orapred.
The license in connection with Orapred could be terminated on 30-days notice.
Primsol solution, an antibiotic for acute otitis media, and Orapred, an asthma treatment in an improved-tasting formulation of liquid prenisolone sodium phosphate, could be launched in the second half of this year pending approval by the Food and Drug Administration.
The company recently gained FDA [Food & Drug Administration] and European approval for another product, Naglazyme, for the treatment of MPS-VI and Orapred ODT for asthma in children.